Showing results (1001-1010 of 15,775) with videos related to

Sort By:
Pageof 1,578
The Journal of Antimicrobial Chemotherapy|May 16, 2021
Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort studyTanya Babich, Pontus Naucler, John Karlsson Valik, et al.
The Journal of Antimicrobial Chemotherapy|May 16, 2021
Staphylococcal cassette chromosome mec containing a novel mec gene complex, B4Artur J Sabat, Erik Bathoorn, Karsten Becker, et al.
The Journal of Antimicrobial Chemotherapy|August 4, 2021
Variations in pharmacokinetic-pharmacodynamic target values across MICs and their potential impact on determination of susceptibility test interpretive criteriaUrsula Waack, Abhay Joshi, Seong H Jang, et al.
The Journal of Antimicrobial Chemotherapy|May 29, 2020
In vitro susceptibility to fostemsavir is not affected by long-term exposure to antiviral therapy in MDR HIV-1-infected patientsFrancesco Saladini, Alessia Giannini, Federica Giammarino, et al.
The Journal of Antimicrobial Chemotherapy|May 29, 2020
Structural and biochemical characterization of the environmental MBLs MYO-1, ECV-1 and SHD-1Christopher Fröhlich, Vidar Sørum, Sandra Huber, et al.
The Journal of Antimicrobial Chemotherapy|May 29, 2020
Determining the optimal dosing of a novel combination regimen of ceftazidime/avibactam with aztreonam against NDM-1-producing Enterobacteriaceae using a hollow-fibre infection modelThomas P Lodise, Nicolas M Smith, Nick O'Donnell, et al.
The Journal of Antimicrobial Chemotherapy|May 20, 2021
Prevalence of genotypic baseline risk factors for cabotegravir + rilpivirine failure among ARV-naive patientsCharlotte Charpentier, Alexandre Storto, Cathia Soulié, et al.
The Journal of Antimicrobial Chemotherapy|August 12, 2021
Intrapulmonary pharmacokinetic profile of cefiderocol in mechanically ventilated patients with pneumoniaTakayuki Katsube, David P Nicolau, Keith A Rodvold, et al.
The Journal of Antimicrobial Chemotherapy|August 12, 2021
Novel FtsZ inhibitor with potent activity against Staphylococcus aureusManoj Kumar, Tarun Mathur, Tarani Kanta Barman, et al.
The Journal of Antimicrobial Chemotherapy|August 2, 2021
Effect of efavirenz-based ART on the pharmacokinetics of rifampicin and its primary metabolite in patients coinfected with TB and HIVJesper Sundell, Emile Bienvenu, Angela Äbelö, et al.
Pageof 1,578